In our study, we showed that tangeretin had antiproliferative effects on breast cancer cells and reduced BCSC proliferation or prevalence through a decrease in Sox2 expression by inhibiting Stat3 signaling. This evidence concerns the gene SOX2 and breast carcinoma.